COVID-19 has raised a plethora of ethical issues – from prevention and containment, to cure and management. Join leading experts to discuss these issues in a Bioethics Interest Group (BIG) webinar series focused on COVID-19 ethical considerations. Hosted by the Office of Research Excellence and moderated by Adnan Hyder, Senior Associate Dean for Research, these […]
Global response to COVID-19 pandemic has inadvertently undermined the achievement of existing public health priorities and laregely overlooked local context. Recent evidence suggests that this will cause additional maternal and childhood mortality and morbidity especially in low- and middle-income countries (LMICs). This paper explores the contextual factors influencing maternal, neonatal and children health (MNCH) care in […]
As the COVID-19 vaccination programme starts to be rolled out, many young women are hesitant to accept the vaccine, citing concerns about fertility. Meanwhile, those offered the vaccine during pregnancy must decide whether they will accept, even though pregnant people were excluded from the clinical trials. Data on accidental pregnancies that occurred during the trials […]
TrialX talked to reproductive endocrinologist & virologist Dr Cindy Duke of Nevada Fertility Institute to get answers to common questions and clear the air around myths related to use of COVID-19 vaccines in women who are pregnant, breastfeeding or trying to conceive naturally/via ART, and dig deeper into why the CDC quotes “they are unlikely […]
Now more than ever, women who are pregnant or are thinking of becoming pregnant will need to make decisions about getting a vaccine In this Impact Factor episode, Dr F. Perry Wilson of the Yale School of Medicine, discusses new hard data on the risks of COVID-19 in pregnancy.
Continued provision of essential sexual and reproductive health services remains critical during the global response to the pandemic. IAWG members and partners are producing clinical and programmatic guidance, assessments, policy papers, and statements to ensure continued prioritization of sexual and reproductive health and rights throughout COVID-19 response in humanitarian settings, and to bring a gender […]
The health, economic, and social impacts of COVID-19 are felt worldwide and most critically by those who are at risk of exposure, severe forms of illness, mortality, and those facing the brunt of the economic downturn. There is a risk that existing inequalities in maternal and reproductive health outcomes will be exacerbated, if we don’t […]
The coronavirus pandemic has impacted women’s reproductive health in many ways and in all likelihood will continue to do so for years to come. In the midst of the madness, experts from two leading reproductive health businesses weigh in with their thoughts on how COVID-19 has altered the landscape for women, aspiring parents, and babies […]
During this era of COVID-19, older people and those with underlying health conditions have been considered most at risk of developing severe illness and death. However, there are other exposed populations, including pregnant women, who may also be susceptible to increased medical and social risks, as we have seen with previous disease outbreaks. This article discusses the […]
Women Deliver, together with its partners, has been working with leaders and mobilisers across the globe to outline key actions that civil society, governments, the private sector, and multilateral organisations should take to address the gendered dimensions of the COVID-19 crisis. Recommendations range from better data utilisation to health, social, and economic investments.